Cocaine: Difference between revisions

No edit summary
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
''This page is for the drug cocaine; for clinical effects see [[cocaine toxicity]]''
''This page is for the drug cocaine; for clinical effects see [[cocaine toxicity]]''
==Administration==
==Administration==
*Type:  
*Type: Local anesthetic
*Dosage Forms:
*Dosage Forms: 4% solution; 10% solution
*Routes of Administration:
*Routes of Administration: Topical
*Common Trade Names:  
*Common Trade Names: Cocaine


==Adult Dosing==
==Adult Dosing==
 
*1-3 mg/kg, max dose of 200 mg
**Some literature suggests maximum dose of 100 mg
**Ideally use lowest effective dose


==Pediatric Dosing==
==Pediatric Dosing==
 
*1 mg/kg
**No clear safe dose established


==Special Populations==
==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]:
*[[Drug pregnancy categories|Pregnancy Rating]]: Category C
*Lactation risk:
*Lactation risk: Infant risk has been demonstrated
===Renal Dosing===
===Renal Dosing===
*Adult:
*Adult: N/A
*Pediatric:
*Pediatric: N/A
===Hepatic Dosing===
===Hepatic Dosing===
*Adult:
*Adult: N/A
*Pediatric:
*Pediatric: N/A


==Contraindications==
==Contraindications==
Line 26: Line 29:


==Adverse Reactions==
==Adverse Reactions==
*Acute
*[[Cocaine-associated chest pain]]
**[[Cocaine-associated chest pain]]
*Sympathomimetic qualities
**Sympathomimetic qualities
**Tachycardia
***Tachycardia
**Fever
***Fever
**Agitation
***Agitation
**Diaphoresis
***Diaphoresis
**Pulmonary Complications:
***"Crack lung"<ref>Forrester, J. M., Steele, A. W., Waldron, J. A. and Parsons, P. E. (1990) ‘Crack Lung: An Acute Pulmonary Syndrome with a Spectrum of Clinical and Histopathologic Findings’, American Review of Respiratory Disease, 142(2), pp. 462–467. doi: 10.1164/ajrccm/142.2.462.</ref>
***Diffuse alveolar hemorrhage<ref>Ettinger, N. A. and Albin, R. J. (1989) ‘A review of the respiratory effects of smoking cocaine’, The American Journal of Medicine, 87(6), pp. 664–668. doi: 10.1016/s0002-9343(89)80401-2.</ref>
***[[ARDS]]
***Acute eosinophilic pneumonia
***[[Pneumothorax]]
***[[Pneumomediastinum]]
***Thermal epiglottitis - hot cocaine
*Chronic
**Atherosclerosis
**Cardiomyopathy
**Nasal Septum damage
**Up to 70% of US cocaine tainted with [[levamisole]], potentially leading to [[neutropenia]], [[vasculitis]]
 


==Pharmacology==
==Pharmacology==
*Half-life:  
*Half-life: 50 to 75 minutes (5.5 hours benzoylecgonine metabolite)
*Metabolism:  
*Metabolism: Plasma cholinesterase; liver
*Excretion:  
*Excretion: Renal


==Mechanism of Action==
==Mechanism of Action==
Line 61: Line 49:


==See Also==
==See Also==
 
*[[Cocaine toxicity]]


==References==
==References==
Micromedex
<references/>
<references/>


[[Category:Pharmacology]]
[[Category:Pharmacology]]
==See Also==
*[[Sympathomimetic toxicity]]
*[[Cocaine toxicity]]
*[[Cocaine Chest Pain]]
*[[Cocaine Withdrawal]]
*[[Levamisole toxicity]]
[[Category:Toxicology]]
[[Category:Pharmacology]]
==References==
<references/>

Latest revision as of 14:35, 16 March 2018

This page is for the drug cocaine; for clinical effects see cocaine toxicity

Administration

  • Type: Local anesthetic
  • Dosage Forms: 4% solution; 10% solution
  • Routes of Administration: Topical
  • Common Trade Names: Cocaine

Adult Dosing

  • 1-3 mg/kg, max dose of 200 mg
    • Some literature suggests maximum dose of 100 mg
    • Ideally use lowest effective dose

Pediatric Dosing

  • 1 mg/kg
    • No clear safe dose established

Special Populations

Renal Dosing

  • Adult: N/A
  • Pediatric: N/A

Hepatic Dosing

  • Adult: N/A
  • Pediatric: N/A

Contraindications

  • Allergy to class/drug

Adverse Reactions

Pharmacology

  • Half-life: 50 to 75 minutes (5.5 hours benzoylecgonine metabolite)
  • Metabolism: Plasma cholinesterase; liver
  • Excretion: Renal

Mechanism of Action

  • Blocks reuptake of serotonin, dopamine and norepinephrine
  • Anesthetic effects achieved through sodium channel blockade

Comments

See Also

References

Micromedex